BUSINESS
Lupin rises on getting USFDA’s approval for Rufinamide Tablets
Lupin is currently trading at Rs. 688.15, up by 0.60 points or 0.09% from its previous closing of Rs. 687.55 on the BSE. The scrip opened at Rs.…
andrew garfield remus lupin
BUSINESS
Lupin rises on getting tentative approval for Ivacaftor Tablets from USFDA
Lupin is currently trading at Rs. 612.10, up by 2.20 points or 0.36% from its previous closing of Rs. 609.90 on the…